| Literature DB >> 7011716 |
R E Chance, E P Kroeff, J A Hoffmann, B H Frank.
Abstract
Human insulin derived via recombinant DNA technology was tested extensively by a complex battery of analytic procedures. This product, which is designated biosynthetic human insulin, was found to be chemically, physically, and immunologically equivalent to pancreatic human insulin and biologically equivalent to both pancreatic human insulin and purified pork insulin.Entities:
Mesh：
Substances：
Year: 1981 PMID： 7011716 DOI： 10.2337/diacare.4.2.147
Source DB: PubMed Journal: Diabetes Care ISSN： 0149-5992 Impact factor: 19.112